Clinical Trial Update: A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating rezatapopt in combination with azacitidine for TP53Y220C mutant myeloid malignancies (acute myeloid leukemia or myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Rezatapopt (rezatapopt)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING